CMIDD - Center for Molecular Innovation and Drug Discovery

Fingerprint Dive into the research topics where CMIDD - Center for Molecular Innovation and Drug Discovery is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.

Fullerenes Chemical Compounds
Molecules Chemical Compounds
Ligands Medicine & Life Sciences
Palladium Chemical Compounds
Quantitative Structure-Activity Relationship Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Fluorination Chemical Compounds
Phosphotransferases Chemical Compounds

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Profiles

Research Output 1988 2019

A novel strategy to block mitotic progression for targeted therapy

Chi, J. J., Li, H., Zhou, Z., Izquierdo-Ferrer, J., Xue, Y., Wavelet, C. M., Schiltz, G. E., Zhang, B., Cristofanilli, M., Lu, X., Bahar, I. & Wan, Y., Nov 2019, In : EBioMedicine. 49, p. 40-54 15 p.

Research output: Contribution to journalArticle

Open Access
Degradation
Tumors
Cells
Neoplasms
Breast Neoplasms

Development of Tetrahydroindazole-Based Potent and Selective Sigma-2 Receptor Ligands

Iyamu, I. D., Lv, W., Malik, N., Mishra, R. K. & Schiltz, G. E., Jul 3 2019, In : ChemMedChem. 14, 13, p. 1248-1256 9 p.

Research output: Contribution to journalArticle

Drug Discovery
Ligands
Central Nervous System Diseases
Neurology
Solubility
2 Citations (Scopus)

Discovery of a novel class of potent and selective tetrahydroindazole-based sigma-1 receptor ligands

Iyamu, I. D., Lv, W., Malik, N., Mishra, R. K. & Schiltz, G. E., May 1 2019, In : Bioorganic and Medicinal Chemistry. 27, 9, p. 1824-1835 12 p.

Research output: Contribution to journalArticle

Protein Transport
Ligands
Molecular modeling
Central Nervous System Diseases
Structure-Activity Relationship

Grants 2011 2024

Neoplasms
Therapeutics
Bone Marrow Diseases
Mutation
Hematopoiesis
Neuropharmacology
Pharmaceutical Preparations
Ligands
Technology
Neurobiology